← Product Code [LHI](/productcode/LHI) · K980587 # IV DECANTER-FLEXIBLE (K980587) _Inrad · LHI · Apr 17, 1998 · General Hospital · SESE_ **Canonical URL:** https://fda-staging.innolitics.com/device/K980587 ## Device Facts - **Applicant:** Inrad - **Product Code:** [LHI](/productcode/LHI.md) - **Decision Date:** Apr 17, 1998 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5440 - **Device Class:** Class 2 - **Review Panel:** General Hospital ## Indications for Use Aseptic Decanting of fluids from flexible containers ## Device Story The Inrad IV Decanter-Flexible is a fluid transfer device consisting of a flexible tube with an integrated spike at one end for connection to a flexible fluid container and a clamp to control fluid flow. It is used to facilitate the aseptic transfer of fluids. The device is intended for use by healthcare professionals. It functions as a manual mechanical accessory for fluid management. ## Clinical Evidence Bench testing only; no clinical data provided. ## Technological Characteristics Device consists of plastic tubing, a spike, and a flow control clamp. No patient contact materials. Biocompatibility testing performed. Manual operation; no energy source or software. ## Regulatory Identification An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container. ## Special Controls *Classification.* Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9. ## Predicate Devices - Medtronic/DLP IV Decanter ([K812852](/device/K812852.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K980587 ## 510(K) SUMMARY OF SAFETY AND EFFECTIVENESS (As required by 21 CFR 807.92(c)) - 1. INDICATIONS: The indications or intended use for the Inrad IV Decanter - Flexible as well as the predicate device, Medtronic/DLP "IV Decanter" (K812852) are the same. Both have the same indications, which is for dispensing fluids from flexible containers. - 2. DESIGN: The design of the Inrad IV Decanter Flexible is similar to the predicate device referenced in the Comparison Information Section. It features a flexible tube with a spike attached at one end for attaching to the flexible bag. A clamp is furnished as a means of stopping the fluid flow from the bag which is the same as the Medtronic/DLP "IV Decanter". - 3. MATERIALS: The device is manufactured from plastic which has no patient contact. The device has been tested for biocompatibility based on these conditions. - 4. SAFETY AND EFFECTIVENESS: There are no differences in safety and effectiveness. The materials have undergone acceptable biocompatibility testing. The intended use is the same as Medtronic/DLP "IV Decanter" predicate product. Design characteristics are similar to the Medtronic/DLP "IV Decanter" predicate product. - 5. DIFFERENCES: Primary difference between the Inrad "IV Decanter" and Medtronic/DLP "IV Decanter" is the color of the tubing which is used to distinguish the two products from one another. Ome Armstrong Anne Armstrong Director Quality Assurance/Regulatory Affairs Inrad Incorporated 3956 44th St. SE Kentwood, MI 49512 Phone:(616) 554-7750 Ext. 102 Fax: (616) 554-7751 {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three stylized human profiles facing to the right. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 17 1998 Ms. Anne Armstrong Director Quality Assurance and Regulatory Affairs Inrad Incorporated 3956 44th Street S.E. Kentwood, Michigan 49512 Re : K980587 Trade Name: IV Decanter-Flexible Regulatory Class: II Product Code: LHI Dated: February 13, 1998 Received: February 17, 1998 Dear Ms. Armstrong: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of {2}------------------------------------------------ Page 2 - Ms. Armstrong the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fdalqov/cdrh/dsmamain.html". Sincerely yours Timothy Whetstone Diredtor Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## K980587 510 (k) Number (IF Known): K980587 Device Name: Indications for Use: #40050 IV DECANTER- FLEXIBLE Aseptic Decanting of fluids from flexible containers Image /page/3/Figure/7 description: This image shows a document with some text. On the right side, the text reads "FDA/CDRH/ODE/DMC". On the left side, the text reads "RECEIVED". In the middle, the text reads "24 FEB 98 10 25". (Please Do Not Write Below This Line - Continue on Another Page If Needed) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter-Use (Optional Format 1-2-96) Patrizia Cucorete (Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number_4980587 SK-11 --- **Source:** [https://fda-staging.innolitics.com/device/K980587](https://fda-staging.innolitics.com/device/K980587) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com